Cisatracurium besylate is the latest generation of muscle relaxant. Compared with the major clinical muscle relaxants, this product has the characteristics of metabolism through non-hepatic and non-renal pathways and cardiovascular stability.Atracurium is mainly used in general anesthesia, and can be widely used in endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery and elderly and pediatric patients.Since the drug was first marketed in the UK in 1996, it has gradually replaced vecuronium bromide and atracurium in foreign countries and become the mainstream of clinical muscle relaxants.

Market Analysis and Insights: Global Cisatracurium Besylate Market
In 2020, the global Cisatracurium Besylate market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Cisatracurium Besylate Scope and Market Size
The global Cisatracurium Besylate market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Cisatracurium Besylate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Solution
Injection

Segment by Application
General Anesthesia
Endotracheal Intubation
Liver And Kidney Dysfunction
Cardiovascular Surgery
Old Families
Pediatric
Other

By Company
GSK
Aspen Pharmacare
AbbVie
Abbott
Pfizer
Mylan Pharmaceuticals
Fresenius Kabi
Omega Laboratories Ltd
Somerset Therapeutics
Jiangsu Hengrui Medicine
Shanghai Pharmaceuticals Holding
Zhejiang Xianju

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE